Mesoblast LTD (MEOBF) SEC Filings — 2024
38 SEC filings for Mesoblast LTD (MEOBF) in 2024.
Filings
- Mesoblast Ltd Announces New Share Issuance — 6-K · Dec 23, 2024
- Mesoblast Ltd Files 6-K Report — 6-K · Dec 20, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Dec 16, 2024
- Mesoblast Ltd Files December 2024 Update — 6-K · Dec 9, 2024
- Mesoblast Ltd Files 6-K with SEC — 6-K · Dec 4, 2024
- Mesoblast Files Director Interest Notice — 6-K · Nov 18, 2024
- Mesoblast Ltd Announces New Equity Issue — 6-K · Nov 13, 2024
- Mesoblast Ltd Files Quarterly Report — 6-K · Nov 1, 2024
- Mesoblast Files Annual Report and Shareholder Meeting Notices — 6-K · Oct 18, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Oct 9, 2024
- Mesoblast Ltd Files 6-K with ASX Announcement — 6-K · Oct 1, 2024
- Mesoblast Ltd. Files 20-F Annual Report — 20-F · Aug 29, 2024
- Mesoblast Ltd Files Quarterly Report — 6-K · Aug 1, 2024
- Mesoblast Ltd Files Form 6-K with SEC — 6-K · Jul 25, 2024
- Mesoblast Ltd. Files ASX Announcement — 6-K · Jul 23, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Jul 11, 2024
- Mesoblast Ltd Files 6-K Report — 6-K · Jul 10, 2024
- Mesoblast Ltd Files 6-K Report — 6-K · Jul 2, 2024
- Mesoblast Ltd Files June 2024 6-K Report — 6-K · Jun 4, 2024
- Mesoblast Ltd. Announces New Share Issue & Director Interest Changes — 6-K · May 10, 2024
- Mesoblast Ltd. Announces Share Issuance and Director Interest Changes — 6-K · May 3, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · May 3, 2024
- Mesoblast Ltd Files Quarterly Report — 6-K · May 1, 2024
- Mesoblast Ltd Files Appendix 3H with ASX — 6-K · Apr 17, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Apr 9, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Apr 3, 2024
- Mesoblast Ltd Files 6-K Report with SEC — 6-K · Mar 27, 2024
- Mesoblast Ltd. Proposes New Securities Issue — 6-K · Mar 21, 2024
- Mesoblast LTD SC 13G/A Filing — SC 13G/A · Mar 20, 2024
- Mesoblast Completes Phase 3 Trial for aGVHD — 6-K · Mar 15, 2024
- Mesoblast Ltd Files 6-K Report — 6-K · Mar 12, 2024
- Mesoblast Ltd Files 6-K with SEC — 6-K · Mar 1, 2024
- Mesoblast Narrows H1 Loss to $22.3M, Cash Declines — 6-K · Feb 29, 2024
- Mesoblast Files 6-K, Updates ASX on February 15th Release — 6-K · Feb 21, 2024
- MESOBLAST FILES Q4 2023 QUARTERLY REPORT (APPENDIX 4C) — 6-K · Feb 1, 2024
- MESOBLAST'S REVASCOR GETS FDA RARE PEDIATRIC DISEASE DESIGNATION — 6-K · Jan 23, 2024
- MESOBLAST FILES 6-K: NEW EQUITY, CESSATION, DIRECTOR INTERESTS — 6-K · Jan 16, 2024
- MESOBLAST MODIFIES ADR RATIO TO 10:1, CONSOLIDATING SHARES — 6-K · Jan 5, 2024